For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted ...

For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to ...

Treatment practices in the U.S. show approximately 75% of diagnosed pulmonary sarcoidosis patients require treatment with ...

ATS 2025, San Francisco – Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research published ...

A new biologic drug has been given to a patient with pulmonary sarcoidosis for the first time. The drug, infliximab, was administered at the John Radcliffe Hospital, part of Oxford University ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks, the randomized PREDMETH trial showed. Mean change from baseline in ...

The pulmonary sarcoidosis treatment landscape is poised for substantial transformation in the coming years, with the 7MM market expected to witness considerable growth by 2032. This expansion is ...

Shukla, M.D., M.S., President and Chief Executive Officer of aTyr. “The program’s cornerstone is our Phase 3 EFZO-FIT™ study ...

As the effects of wildfires persist in several parts of the United States, McGowan highlighted a public health alert ...